SLC25A1 and cancer: Blocking of the citrate transport from mitochondria into the cytoplasm with an SLC25A1 inhibitor, benzenetricarboxylate (BTA), had several effects on cancer cells including increased glycolysis, ROS synthesis, mitophagy and disrupted mitochondrial homeostasis (Catalina-Rodriguez et al., 2012; Kolukula et al., 2014; Fernandez et al., 2018).